Accordingly, several potential molecular drivers of HCC have been identified, including mutations in TP53, CTNNB1, and TERT promoter [3], and metabolic genes such as ALB, CPS1, and APOB [4]. The gene discussed is TP53; the disease is hepatocellular carcinoma.